Cedar, the patient financial engagement company, appeared in an NBC segment alongside OpenAI and QuantHealth as artificial intelligence deployment expands across different parts of the healthcare system.
OpenAI said it is developing a new AI model focused on life sciences and drug discovery. The company is targeting pharmaceutical research workflows, where timelines and costs remain high.
QuantHealth is applying AI to clinical trials. The company uses simulation models to identify which drugs are more likely to succeed, with the aim of reducing development timelines. A company representative said AI could cut the time required for drug approval by half within 10 years.


